MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.09.24 Share Price

Warrant

DE000MB09UT7

Market Closed - Börse Stuttgart 19:08:31 10/05/2024 BST
0.021 EUR +5.00% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.09.24
Current month+5.00%
1 month-16.00%
Date Price Change Volume
10/05/24 0.021 +5.00% 0
09/05/24 0.02 0.00% 0
08/05/24 0.02 -4.76% 0
07/05/24 0.021 +10.53% 0
06/05/24 0.019 -5.00% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 07:08 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB09UT
ISINDE000MB09UT7
Date issued 08/11/2022
Strike 160 $
Maturity 20/09/2024 (133 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.003
Spread 0.019
Spread %47.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.7 USD
Average target price
126.1 USD
Spread / Average Target
+20.43%
Consensus